{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:51:08Z","timestamp":1753876268699,"version":"3.41.2"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Left ventricular outflow tract obstruction (LVOTO) is common in hypertrophic cardiomyopathy (HCM) but has not been reported in hereditary transthyretin amyloidosis (ATTRv).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Case summary<\/jats:title>\n                  <jats:p>Here, we describe a 67-year-old male patient with a hypertrophic phenotype who was initially diagnosed with LVOTO attributed to HCM. Echocardiographic features included a hyperdynamic left ventricular ejection fraction, severe septal hypertrophy, and elongated residual mitral leaflets permitting their systolic anterior motion. The patient was childless, and family history was negative for any cardiovascular disease. Significant coronary artery disease was diagnosed. In cardiac magnetic resonance imaging, the concurrent presence of different late enhancement patterns initially prevented an unequivocal diagnosis. Due to progressive neuropathy, genetic testing for ATTRv was performed and identified a pathogenic variant in the TTR gene. Cardiac involvement was confirmed by amyloid scintigraphy with a Perugini score of 3, and treatment with ribonucleic acid silencing therapy was commenced.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The present case illustrates that LVOTO can occur in patients with ATTRv. While cardiac imaging pointed towards sarcomeric HCM, the coexisting red flags initiated re-evaluation of the diagnosis suggesting cardiac amyloidosis as a potential cause. The presence of non-cardiac red flags of transthyretin amyloidosis (ATTR) should initiate specific diagnostic work-up even if ATTR is unlikely based on cardiac imaging.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytaf029","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T17:34:42Z","timestamp":1737653682000},"source":"Crossref","is-referenced-by-count":0,"title":["Variant cardiac transthyretin amyloidosis presenting as hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: a case report"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7024-2131","authenticated-orcid":false,"given":"Viktoria","family":"H\u00f6ller","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Medical University of Graz , Auenbruggerplatz 15, 8036 Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viktoria","family":"Santner","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Medical University of Graz , Auenbruggerplatz 15, 8036 Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Schmid","sequence":"additional","affiliation":[{"name":"Division of General Radiology, Department of Radiology, Medical University of Graz , Auenbruggerplatz 9, 8036 Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Zirlik","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Medical University of Graz , Auenbruggerplatz 15, 8036 Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7414-4056","authenticated-orcid":false,"given":"Nicolas","family":"Verheyen","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Medical University of Graz , Auenbruggerplatz 15, 8036 Graz ,","place":["Austria"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"key":"2025020611271413400_ytaf029-B1","first-page":"209","article-title":"The diagnosis and treatment of hypertrophic cardiomyopathy","volume":"108","author":"Prinz","year":"2011","journal-title":"Dtsch Arztebl Int"},{"key":"2025020611271413400_ytaf029-B2","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.amjcard.2007.10.031","article-title":"Light-chain amyloidosis with echocardiographic features of hypertrophic cardiomyopathy","volume":"101","author":"Dinwoodey","year":"2008","journal-title":"Am J Cardiol"},{"key":"2025020611271413400_ytaf029-B3","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2025020611271413400_ytaf029-B4","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/ejhf.2532","article-title":"Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies","volume":"24","author":"Aimo","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"2025020611271413400_ytaf029-B5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ehjci\/jead036","article-title":"Spatial relationship between mitral valve and ventricular septum assessed by resting echocardiography to diagnose left ventricular outflow tract obstruction in hypertrophic cardiomyopathy","volume":"24","author":"Verheyen","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2025020611271413400_ytaf029-B6","doi-asserted-by":"crossref","first-page":"ytae317","DOI":"10.1093\/ehjcr\/ytae317","article-title":"Complex management of Fabry cardiomyopathy: a case report on the use of alcohol septal ablation and chaperone therapy","volume":"8","author":"Neculae","year":"2024","journal-title":"Eur Heart J Case Rep"},{"key":"2025020611271413400_ytaf029-B7","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1016\/j.jcin.2021.05.041","article-title":"Worsening heart failure after transcatheter aortic valve replacement: unmasking the left ventricular outflow tract obstruction","volume":"14","author":"Verheyen","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"2025020611271413400_ytaf029-B8","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.amjcard.2020.02.013","article-title":"Distinctive hypertrophic cardiomyopathy anatomy and obstructive physiology in patients admitted with takotsubo syndrome","volume":"125","author":"Sherrid","year":"2020","journal-title":"Am J Cardiol"},{"key":"2025020611271413400_ytaf029-B9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cardfail.2023.10.279","article-title":"Left ventricular outflow tract obstruction in cardiac amyloidosis","volume":"30","author":"Longinow","year":"2024","journal-title":"J Card Fail"},{"key":"2025020611271413400_ytaf029-B10","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1002\/ehf2.14971","article-title":"Prevalence and characteristics of transthyretin amyloid cardiomyopathy in hypertrophic cardiomyopathy","volume":"11","author":"Garcia-Pavia","year":"2024","journal-title":"ESC Heart Fail"},{"key":"2025020611271413400_ytaf029-B11","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"2025020611271413400_ytaf029-B12","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/ana.26845","article-title":"Disease-modifying drugs extend survival in hereditary transthyretin amyloid polyneuropathy","volume":"95","author":"Ueda","year":"2024","journal-title":"Ann Neurol"},{"key":"2025020611271413400_ytaf029-B13","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1002\/ccd.30411","article-title":"Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: new indication for an established therapy","volume":"100","author":"Fanta","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"2025020611271413400_ytaf029-B14","first-page":"e62633","article-title":"Utilizing alcohol septal ablation for mitigating left ventricular outflow tract obstruction in cardiac amyloidosis: a case report","volume":"16","author":"Girgis","year":"2024","journal-title":"Cureus"},{"key":"2025020611271413400_ytaf029-B15","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2022.11.022","article-title":"2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"81","author":"Kittleson","year":"2023","journal-title":"J Am Coll Cardiol"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytaf029\/61591456\/ytaf029.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/2\/ytaf029\/61591456\/ytaf029.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/9\/2\/ytaf029\/61591456\/ytaf029.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T11:27:39Z","timestamp":1738841259000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytaf029\/7976885"}},"subtitle":[],"editor":[{"given":"Andreas","family":"Giannopoulos","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Giacomo Tini","family":"Melato","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Aiste Monika","family":"Jakstaite","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Ana","family":"Devesa","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Jack","family":"Haslett","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]},{"given":"Elton","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytaf029","relation":{},"ISSN":["2514-2119"],"issn-type":[{"type":"electronic","value":"2514-2119"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,1,23]]},"article-number":"ytaf029"}}